CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) to Present at VirtualInvestorConferences.com

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), based in Vancouver, Canada, focused on manufacturing pharmaceutical grade quality cannabinoids via synthetic biology, today announced that its CEO and President Trevor Peters will present live at VirtualInvestorConferences.com at 12:00 p.m. Eastern Time on Thursday, July 9. Interested parties are encouraged to visit www.VirtualInvestorConferences.com to pre-register and run the … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) to Present at VirtualInvestorConferences.com”

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Appoints New SVP to Lead Sales and Marketing of New Line of Cannabinoids

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) on Monday announced that Christopher Speed has joined the Company as Senior Vice President, Sales and Marketing, effective July 1, 2020. In this role, Speed will be responsible for leading the sales and marketing of Willow’s new line of cannabinoids, along with the Company’s strategic planning and customer initiatives. … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Appoints New SVP to Lead Sales and Marketing of New Line of Cannabinoids”

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Announces Further Acceleration of Path to Commercialization, Expands Portfolio

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), a Canadian biotechnology company creating high purity, plant-derived compounds for the global pharmaceutical, health and wellness and consumer packaged goods industries, today announced further acceleration of its path to commercialization following continued scale-up development success and the addition of multiple new cannabinoids for production. “Willow’s scientific and operational success … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Announces Further Acceleration of Path to Commercialization, Expands Portfolio”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Holds Potential to Supply Biosynthetically Derived Cannabinoids

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, is well positioned to disrupt the cannabis industry supply chain by utilizing its ability to provide biosynthetically derived cannabinoids. A recent article discussing the company reads, “Willow ultimately intends to biosynthetically produce a variety of cannabinoids using biosynthesis, … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Holds Potential to Supply Biosynthetically Derived Cannabinoids”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Commence Trading on the Toronto Stock Exchange on December 5

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Tuesday announced its receipt of final approval to list its common shares on the Toronto Stock Exchange (the “TSX”). According to the update, Willow’s common shares will commence trading on the TSX effective as of the open of the market on Thursday, December 5, 2019. The common shares … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) to Commence Trading on the Toronto Stock Exchange on December 5”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Comments on DEA Descheduling Partner’s CBD

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol (“CBD”), this morning issued a release commenting on the recent news that the U.S. Drug Enforcement Agency (“DEA”) has removed Purisys, LLC’s CBD from Schedule I of the Controlled Substances Act (“CSA”). Purisys, the spin-out entity … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Comments on DEA Descheduling Partner’s CBD”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Receipt of Conditional Approval to List on the Toronto Stock Exchange

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) today announced its receipt of conditional approval from the Toronto Stock Exchange (the “TSX”) to list its common shares on the TSX. According to the update, final approval of the listing is subject to Willow Biosciences meeting certain TSX customary conditions, and Willow will issue a statement upon … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Receipt of Conditional Approval to List on the Toronto Stock Exchange”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Posts Q3 2019 Financial Results, Operations Update

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) on Thursday announced its financial and operating results for the three and nine months ended September 30, 2019. Among other highlights, the company reported that it ended the quarter with around $23.2 million of working capital and $24 million of cash on hand. Willow’s unaudited condensed consolidated interim financial … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Posts Q3 2019 Financial Results, Operations Update”

Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Eyes Opportunity to Provide Biosynthetic Cannabinoids in Market with Explosive Potential

Willow’s plan to provide biosynthetic cannabinoid has potential to disrupt the cannabis-industry supply chain Biosynthetically derived cannabinoids offer unique advantages related to reliability, scalability, quality and cost Key collaboration allows company to capitalize on enormous market opportunity Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, … Continue reading “Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Eyes Opportunity to Provide Biosynthetic Cannabinoids in Market with Explosive Potential”

CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF) today announced its plans to participate in the Cowen 2nd Annual Boston Cannabis Conference, a carefully curated event to represent leading-edge companies across a wide array of products, brands, technologies, services and health care providers in the emerging cannabis industry. According to the update, the event is scheduled to … Continue reading “CannabisNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Announces Plans to Participate in Cowen 2nd Annual Boston Cannabis Conference”

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977